Related references
Note: Only part of the references are listed.Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis
Omar Jabado et al.
RHEUMATOLOGY AND THERAPY (2022)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
Emma C. de Moel et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Overdiagnosis and overtreatment in rheumatology: a little caution is in order
Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2018)
Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study
Diahann T. S. L. Jansen et al.
RMD OPEN (2018)
Pathogenetic insights from the treatment of rheumatoid arthritis
Iain B. McInnes et al.
LANCET (2017)
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
Michaela A. Stoffer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts
S. Ajeganova et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Emilio Martin-Mola et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
Alf Kastbom et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis
Isidoro Gonzalez-Alvaro et al.
PLOS ONE (2016)
Therapeutic implications of autoantibodies in rheumatoid arthritis
Daniel Aletaha et al.
RMD OPEN (2016)
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
Mahmood M. T. M. Ally et al.
BMC MUSCULOSKELETAL DISORDERS (2015)
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
Paul Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review
J. A. B. van Nies et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
Arnd Kleyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Repeated Anticitrullinated Protein Antibody and Rheumatoid Factor Assessment Is Not Necessary in Early Arthritis: Results from the ESPOIR Cohort
Laure Gossec et al.
JOURNAL OF RHEUMATOLOGY (2014)
Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study
Clive A. Kelly et al.
RHEUMATOLOGY (2014)
Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register
J. H. Humphreys et al.
ARTHRITIS CARE & RESEARCH (2014)
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
Christoph Boehler et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Forget personalised medicine and focus on abating disease activity
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses
S. Modi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Anticitrullinated Protein Antibodies and Rheumatoid Factor Fluctuate in Early Inflammatory Arthritis and Do Not Predict Clinical Outcomes
Lillian Barra et al.
JOURNAL OF RHEUMATOLOGY (2013)
The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years
Licia Maria Henrique da Mota et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes
J. Bathon et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis
Isidoro Gonzalez-Alvaro et al.
PLOS ONE (2011)
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review
Lillian Barra et al.
RHEUMATOLOGY (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Estimated Cutoff Points for the 28-Joint Disease Activity Score Based on C-reactive Protein in a Longitudinal Register of Early Arthritis
Isabel Castrejon et al.
JOURNAL OF RHEUMATOLOGY (2010)
Outcomes in Recent-Onset Inflammatory Polyarthritis Differ According to Initial Titers, Persistence Over Time, and Specificity of the Autoantibodies
Marie-Caroline Guzian et al.
ARTHRITIS CARE & RESEARCH (2010)
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis
D. M. Lee et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Association Between Anti-Cyclic Citrullinated Peptide Antibodies and Ischemic Heart Disease in Patients With Rheumatoid Arthritis
Francisco Javier Lopez-Longo et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis:: results from a 10-year longitudinal study
S. W. Syversen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis - How to guide individual treatment decisions
Annette H. M. van der Helm-van Mil et al.
ARTHRITIS AND RHEUMATISM (2007)
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset
E Berglin et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis:: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
AHM van der Helm-van Mil et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody
TR Mikuls et al.
ARTHRITIS AND RHEUMATISM (2004)
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
S Rantapää-Dahlqvist et al.
ARTHRITIS AND RHEUMATISM (2003)
Rheumatoid arthritis in Spain:: occurrence of extra-articular manifestations and estimates of disease severity
L Carmona et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Anticitrullinated protein/pepticle antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
O Meyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Akaike's information criterion in generalized estimating equations
W Pan
BIOMETRICS (2001)
Share Paper
